verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: lannett company, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler lannett company, inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 200 mg/1

Manufacturer
Lannett Company, Inc.

Identifiers & Regulatory

Product NDC 62175-486
Product ID 62175-486_c192b40f-4307-483e-bfa7-1619c2f58d7e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020943
Listing Expiration 2026-12-31
Marketing Start 1998-11-25

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62175486
Hyphenated Format 62175-486

Supplemental Identifiers

RxCUI
897584 897590 897596
UPC
0362175486370
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number NDA020943 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62175-486-37)
source: ndc

Packages (1)

62175-486-37 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62175-486-37)

Ingredients (1)

verapamil hydrochloride (200 mg/1)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "c192b40f-4307-483e-bfa7-1619c2f58d7e", "openfda": {"upc": ["0362175486370"], "unii": ["V3888OEY5R"], "rxcui": ["897584", "897590", "897596"], "spl_set_id": ["f3b3580a-4e6b-402f-bf88-f3157d9139b1"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62175-486-37)", "package_ndc": "62175-486-37", "marketing_start_date": "19981125"}], "brand_name": "Verapamil Hydrochloride", "product_id": "62175-486_c192b40f-4307-483e-bfa7-1619c2f58d7e", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "62175-486", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "NDA020943", "marketing_category": "NDA", "marketing_start_date": "19981125", "listing_expiration_date": "20261231"}